Clinical Trial Update: AccuIMR Predicts Microvascular Obstruction and Infarct Size in STEMI Patients

View source ↗

Summary

Clinical trial update showing that AccuIMR can predict microvascular obstruction and infarct size in patients with ST-segment elevation myocardial infarction.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• St-segment Elevation Myocardial Infarction

Snippet

Sponsor: RenJi Hospital | Conditions: Coronary Artery Disease, STEMI - ST Elevation Myocardial Infarction | Status: COMPLETED